関連する実験動画
Updated: Jul 22, 2026
07:58
Characterizing Mutational Load and Clonal Composition of Human Blood
Published on: July 11, 2019
クルーツフェルト・ヤコブ病と輸血
T F Esmonde1, R G Will, J M Slattery
1Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.
Lancet (London, England)
|January 23, 1993
まとめ
輸血はクレッツフェルト・ヤコブ病 (CJD) の主要な危険因子である可能性は低い. 監視データは,対照群と比較して,CJD患者の輸血または献血の頻度が増加していないことを示しました.
科学分野:
- 神経科学は神経科学である.
- エピデミオロジー エピデミオロジー
- 公衆衛生は公衆衛生である.
背景:
- クルーツフェルト・ヤコブ病 (CJD) は,まれで致命的な神経変性疾患である.
- 輸血などの潜在的な感染経路を理解することは,公衆衛生にとって極めて重要です.
- 以前の懸念は,血液製品によるプリオン病の伝播に関するものでした.
研究 の 目的:
- 英国における輸血歴とクレッツフェルト・ヤコブ病 (CJD) の関連性を調査する.
- CJD患者における輸血と献血の頻度を,年齢と性別を合わせた対照群と比較する.
- 血液輸血歴のある患者におけるCJDの臨床的特徴を分析する.
主な方法:
- イギリスにおけるクレウツフェルト・ヤコブ病 (CJD) の確固たるおよび確定的症例の流行病学的監視.
- CJD患者と対照群における輸血と献血歴を比較したケース・コントロール分析.
- 血液輸血歴のある患者の臨床データレビュー.
主要な成果:
- 202人のCJD患者のうち,21人が輸血歴があり,29人が献血歴がありました.
- 輸血や献血の頻度は,CJD患者と対照群の間で有意な差異はなかった.
- 輸血を受けた患者の臨床的特徴は,ヒト成長ホルモンに関連した変異性CJDと異なる古典的なCJDと一致していました.
結論:
- 現在の証拠は,クレウツフェルト・ヤコブ病 (CJD) の主要なリスク因子としての輸血を支持していません.
- この研究は,CJDの伝播に関連して,輸血の安全性に関して安心を与えます.
- 稀有または新興の伝播経路については,さらなる警戒と研究が正当化される可能性があります.
関連する概念動画
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...